A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

New England Journal of Medicine - Tập 350 Số 11 - Trang 1081-1092 - 2004
R. Charles Coombes1, Emma Hall2, Lorna J. Gibson1, Robert Paridaens3, Jacek Jassem4, T. Delozier5, Stephen E. Jones6, Isabel Álvarez7, Gianfilippo Bertelli8, Olaf Ortmann9, Alan S. Coates10, Emilio Bajetta11, David Dodwell12, Robert E. Coleman13, Lesley Fallowfield14, E. Mickiewicz15, Jørn Andersen16, Per Eystein Lønning17, Giorgio Cocconi18, Alan L. Stewart19, Nick Stuart20, Claire Snowdon1, M. Carpentieri21, Giorgio Massimini21, Judith M. Bliss2
1Department of Cancer Medicine, Imperial College and Charing Cross Hospital, London
2Institute of Cancer Research, Sutton
3Universitair Ziekenhuis, Leuven, Belgium
4Medical University of Gdansk, Gdansk, Poland
5Centre François Baclesse Caen, France
6U.S. Oncology Research, Houston
7Hospital Donostia, San Sebastián, Spain
8South West Wales Cancer Institute, Swansea
9University of Regensburg, Regensburg, Germany
10University of Sydney, Sydney, Australia
11Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
12Cookridge Hospital, Leeds
13Cancer Research Centre, Weston Park Hospital, Sheffield
14Psychosocial Oncology Group, University of Sussex, Brighton
15Instituto Angel Roffo, Buenos Aires, Argentina
16Århus University Hospital, Århus, Denmark
17Haukeland Hospital, University of Bergen, Bergen, Norway
18University Hospital, Parma, Italy
19Christie Hospital, Manchester
20Ysbyty Gwynedd, Bangor, Gwynedd
21Pharmacia Italia, Pfizer Group, Nerviano, Italy

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1016/S0140-6736(01)72307-0

Jensen EV, 2003, Clin Cancer Res, 9, 1980

10.1038/bjc.1971.33

10.1007/BF00713399

10.1016/S0140-6736(97)11423-4

10.1093/jnci/88.24.1791

10.1093/jnci/88.21.1529

10.1200/JCO.2003.04.576

10.1038/nrc721

10.1002/(SICI)1097-0142(19980915)83:6<1142::AID-CNCR13>3.3.CO;2-7

Dombernowsky P, 1998, J Clin Oncol, 16, 453, 10.1200/JCO.1998.16.2.453

Evans TR, 1992, Cancer Res, 52, 5933

10.1016/0022-4731(88)90129-X

10.1023/A:1008368300827

Geisler J, 1998, Clin Cancer Res, 4, 2089

Lonning PE, 2000, J Clin Oncol, 18, 2234, 10.1200/JCO.2000.18.11.2234

10.1093/annonc/mdg362

10.1111/j.1749-6632.2001.tb04027.x

10.1056/NEJMoa032312

Cox DR, 1972, J R Stat Soc [B], 34, 187

10.1056/NEJM199203263261302

1992, Lancet, 339, 71, 10.1016/0140-6736(92)90997-H

10.1093/jnci/88.24.1834

10.1093/jnci/88.21.1543

10.1016/S0140-6736(02)09088-8

Boccardo F, 2001, J Clin Oncol, 119, 4209, 10.1200/JCO.2001.19.22.4209

Boccardo F, 2003, Breast Cancer Res Treat, 82, S6

10.1038/sj.onc.1205420

10.1074/jbc.M010840200

Dowsett M, 2003, Breast Cancer Res Treat, 82, S7

10.1093/jnci/90.18.1371

10.1016/S0140-6736(03)12342-2

10.1093/jnci/86.7.527

10.1093/jnci/87.9.645

10.1093/annonc/mdf083

Harper-Wynne C, 2002, Cancer Epidemiol Biomarkers Prev, 11, 614

Donnellan PP, 2001, J Clin Oncol, 19, 2767, 10.1200/JCO.2001.19.10.2767

10.1093/jnci/82.16.1327

10.1093/annonc/mdh064